Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2021-10-18 00:00:00 ET · period of report 2021-10-14 · accession 0001593968-21-002277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-18 | 2021-10-14 | LFCR | Schechter Joshua | Dir | A - Grant | $9.77 | +5,398 | 5,398 | New | +$52.7K |
| D | 2021-10-18 | 2021-10-14 | LFCR | Schechter Joshua | Dir | M - OptEx | $9.77 | -5,398 | 0 | -100% | -$52.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-14 | A | A | 5,398 | $9.77 | 5,398 | D | — | — | (F1) The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| 2 | Derivative | Restricted Stock Unit | 2021-10-14 | M | D | 5,398 | $9.77 | 0 | D | — · 2021-10-14 to 2021-10-14 | 5,398 Common Stock | (F2) The restricted stock units were granted on October 14, 2020. (F1) The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. (F3) The restricted stock units vested on October 14, 2021. |